New Delhi, Aug. 12 -- Apollo Hospitals Enterprise Ltd beat street estimates for the June quarter as high speciality volumes continued to boost growth, and the hospital chain continued its capacity exp... Read More
New Delhi, Aug. 7 -- Biocon is not rushing to react to proposed US tariffs on generic drugs in its largest market as it sees the move as a negotiation tactic rather than a real threat, executive chair... Read More
New Delhi, Aug. 6 -- Diagnostics major Metropolis Healthcare is accelerating its expansion into India's tier-II and tier-III markets, capitalizing on a multi-year investment push designed to capture a... Read More
Mumbai, Aug. 1 -- Sun Pharmaceutical Industries, India's biggest drugmaker by market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on p... Read More
New Delhi, July 31 -- Sun Pharmaceutical Industries, India's largest drugmaker market capitalization, missed Street expectations in the June quarter as weakness in its US generics business weighed on ... Read More
New Delhi, July 30 -- India's domestic pharmaceutical market is emerging as a bright spot for drugmakers, helping companies with a strong local franchise outpace peers exposed to the increasingly chal... Read More
New Delhi, July 26 -- Last week, US President Donald Trump announced a phased tariff plan for low-cost generic drugs, with the aim of bringing manufacturing back to the US. While many believe the plan... Read More
New Delhi, July 23 -- Cipla, which posted its financial results for the June quarter on Thursday, saw its profits dip 39% over softer US sales. However, the company expects sequential sales momentum i... Read More
New Delhi, July 22 -- US President Donald Trump has announced a phased tariff plan on imported generic medicines that will escalate duties to 200% by 2029 if foreign manufacturers-led by India's multi... Read More
New Delhi, July 21 -- The Indian pharmaceutical sector is expected to post healthy revenue growth in the April-June quarter (Q1FY27), supported by domestic demand and acquisitions, but the US business... Read More